Pharmacological strategies against cold ischemia reperfusion injury

Expert Opinion on Pharmacotherapy

Volumn 11, Issue 4, 2010, Pages 537-555

  Zaouali, Mohamed Amine ^a   Abdennebi, Hassen Ben ^b   Padrissa Altés, Susagna ^a   Mahfoudh Boussaid, Asma ^b   Roselló Catafau, Joan ^a,c  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b UNIVERSITY OF MONASTIR   (Tunisia)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Cold ischemia reperfusion injury; Endothelins; Melatonin; Polyethylene glycol; Preservation solution; Trimetazidine; Trophic factor; UW

Indexed keywords

1 [7 (4 FLUOROPHENYL) 1,2,3,4 TETRAHYDRO 8 (4 PYRIDYL)PYRAZOLO[5,1 C][1,2,4]TRIAZIN 2 YL] 2 PHENYLETHANEDIONE; 1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 3 [2 [(2 TERT BUTYLPHENYLAMINOOXALYL)AMINO]PROPIONYLAMINO] 4 OXO 5 (2,3,5,6 TETRAFLUOROPHENOXY)PENTANOIC ACID; BUCILLAMINE; CARDIOTROPHIN 1; CELSIOR; DEFEROXAMINE; ENDOTHELIN 1; ENDOTHELIN RECEPTOR ANTAGONIST; ERYTHROPOIETIN; EURO COLLINS SOLUTION; FIBROBLAST GROWTH FACTOR; HTK SOLUTION; HYALURONIDASE; IGL 1; MACROGOL; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MELATONIN; NISOLDIPINE; PIFITHRIN ALPHA; PRESERVATION SOLUTION; PYRROLIDINE DITHIOCARBAMATE; RECOMBINANT VASCULOTROPIN; S NITROSOGLUTATHIONE; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 1; TAK 044; TRIMETAZIDINE; UNCLASSIFIED DRUG; UNIVERSITY OF WISCONSIN SOLUTION; VASCULOTROPIN;

ANTIGEN EXPRESSION; CELL DEATH; CELL SWELLING; COLD ISCHEMIA; DRUG FORMULATION; DRUG MECHANISM; EDEMA; ENDOPLASMIC RETICULUM STRESS; HUMAN; LACTIC ACIDOSIS; LIVER ISCHEMIA; MITOCHONDRION; NONHUMAN; ORGAN PRESERVATION; OXIDATIVE STRESS; REPERFUSION INJURY; REVIEW;

COLD ISCHEMIA; COLD TEMPERATURE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MELATONIN; ORGAN PRESERVATION; ORGAN PRESERVATION SOLUTIONS; PERFUSION; POLYETHYLENE GLYCOLS; RECEPTORS, ENDOTHELIN; REPERFUSION INJURY; TISSUE AND ORGAN PROCUREMENT; TRIMETAZIDINE;

EID: 77249156467     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656560903547836     Document Type: Review

References (202)

1. Belzer FO, Southard JH. Principles of solid-organ preservation by cold storage. Transplantation 1988;45(4):673-6 • Basis on solid organ preservation.
2. Huang H, He Z, Roberts LJ II, Salahudeen AK. Deferoxamine reduces cold-ischemic renal injury in a syngeneic kidney transplant model. Am J Transplant 2003;3(12):1531-7
3. Cho YW, Terasaki PI, Cecka JM, Gjertson DW. Transplantation of kidneys from donors whose hearts have stopped beating. N Engl J Med 1998;338(4):221-5
4. Metcalfe MS, Butterworth PC, White SA, et al. A case-control comparison of the results of renal transplantation from heart-beating and non-heart-beating donors. Transplantation 2001;71(11):1556-9
5. Rudich SM, Kaplan B, Magee JC, et al. Renal transplantations performed using non-heart-beating organ donors: going back to the future? Transplantation 2002;74(12):1715-20
6. Salahudeen AK. Cold ischemic injury of transplanted organs: some new strategies against an old problem. Am J Transplant 2004;4(1):1
7. Caldwell-Kenkel JC, Currin RT, Tanaka Y, et al. Kupffer cell activation and endothelial cell damage after storage of rat livers: effects of reperfusion. Hepatology 1991;13(1):83-95
8. Cywes R, Packham MA, Tietze L, et al. Role of platelets in hepatic allograft preservation injury in the rat. Hepatology 1993;18(3):635-47
9. Scheinichen D, zu Vilsendorf AM, Weissig A, et al. Reduced P-selectin expression on circulating platelets after prolonged cold preservation in renal transplantation. Clin Transplant 2003;17(5):444-50
10. Kukan M, Haddad PS. Role of hepatocytes and bile duct cells in preservation-reperfusion injury of liver grafts. Liver Transpl 2001;7(5):381-400
11. Maathuis MH, de Groot M, Ploeg RJ, Leuvenink HG. Deterioration of endothelial and smooth muscle cell function in DCD kidneys after static cold storage in IGL-1 or UW. J Surg Res 2009;152(2):231-7
12. Ramalho FS, Fernandez-Monteiro I, Rosello-Catafau J, Peralta C. Hepatic microcirculatory failure. Acta Cir Bras 2006;21(Suppl 1):48-53
13. Stolz DB, Ross MA, Ikeda A, et al. Sinusoidal endothelial cell repopulation following ischemia/reperfusion injury in rat liver transplantation. Hepatology 2007;46(5):1464-75
14. Rauen U, Polzar B, Stephan H, et al. Cold-induced apoptosis in cultured hepatocytes and liver endothelial cells: mediation by reactive oxygen species. FASEB J 1999;13(1):155-68
15. Kohli V, Selzner M, Madden JF, et al. Endothelial cell and hepatocyte deaths occur by apoptosis after ischemia-reperfusion injury in the rat liver. Transplantation 1999;67(8):1099-105
16. Sindram D, Kohli V, Madden JF, Clavien PA. Calpain inhibition prevents sinusoidal endothelial cell apoptosis in the cold ischemic rat liver. Transplantation 1999;68(1):136-40
17. Natori S, Higuchi H, Contreras P, Gores GJ. The caspase inhibitor IDN-6556 prevents caspase activation and apoptosis in sinusoidal endothelial cells during liver preservation injury. Liver Transpl 2003;9(3):278-84
18. Zhu J, Wang S, Bie P, et al. Apoptosis and regeneration of sinusoidal endothelial cells after extended cold preservation and transplantation of rat liver. Transplantation 2007;84(11):1483-91
19. Song SW, Guo KJ, Shi R, et al. Pretreatment with calcitonin gene-related peptide attenuates hepatic ischemia/ reperfusion injury in rats. Transplant Proc 2009;41(5):1493-8
20. Kuwana T, Newmeyer DD. Bcl-2-family proteins and the role of mitochondria in apoptosis. Curr Opin Cell Biol 2003;15(6):691-9
21. Heimlich G, McKinnon AD, Bernardo K, et al. Bax-induced cytochrome c release from mitochondria depends on alpha-helices-5 and -6. Biochem J 2004;378(Pt 1):247-55
22. Yinjun L, Jie J, Weilai X, Xiangming T. Homoharringtonine mediates myeloid cell apoptosis via upregulation of pro-apoptotic bax and inducing caspase-3-mediated cleavage of poly (ADP-ribose) polymerase (PARP). Am J Hematol 2004;76(3):199-204
23. Schoemaker MH, Conde de la Rosa L, Buist-Homan M, et al. Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways. Hepatology 2004;39(6):1563-73
24. Malhi H, Gores GJ. Cellular and molecular mechanisms of liver injury. Gastroenterology 2008;134(6):1641-54
25. Green DR, Kroemer G. The pathophysiology of mitochondrial cell death. Science 2004;305(5684):626-9
26. Pagliari LJ, Kuwana T, Bonzon C, et al. The multidomain proapoptotic molecules Bax and Bak are directly activated by heat. Proc Natl Acad Sci USA 2005;102(50):17975-80
27. Green DR. Apoptotic pathways: ten minutes to dead. Cell 2005;121(5):671-4
28. Baines CP, Kaiser RA, Purcell NH, et al. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 2005;434(7033):658-62
29. Ohkohchi N, Endoh T, Oikawa K, et al. Fragility of the electron transport chain and superoxide generation in mitochondria of the liver graft after cold ischemia. Transplantation 1999;67(8):1173-7
30. Kerkweg U, Jacob M, De Groot H, et al. Cold-induced apoptosis of rat liver endothelial cells: contribution of mitochondrial alterations. Transplantation 2003;76(3):501-8
31. Bartels-Stringer M, Kramers C, Wetzels JF, et al. Hypothermia causes a marked injury to rat proximal tubular cells that is aggravated by all currently used preservation solutions. Cryobiology 2003;47(1):82-91
32. Belous A, Knox C, Nicoud IB, et al. Altered ATP-dependent mitochondrial Ca2+ uptake in cold ischemia is attenuated by ruthenium red. J Surg Res 2003;111(2):284-9
33. Knox CD, Pierce JM, Nicoud IB, et al. Inhibition of phospholipase C attenuates liver mitochondrial calcium overload following cold ischemia. Transplantation 2006;81(4):567-72
34. Zhang W, Xu C. Calcium sensing receptor and heart diseases. Pathophysiology 2009;16(4):317-23
35. Pallet N, Fougeray S, Beaune P, et al. Endoplasmic reticulum stress: an unrecognized actor in solid organ transplantation. Transplantation 2009;88(5):605-13
36. Duval M, Plin C, Elimadi A, et al. Implication of mitochondrial dysfunction and cell death in cold preservation-warm reperfusion-induced hepatocyte injury. Can J Physiol Pharmacol 2006;84(5):547-54
37. Breckenridge DG, Germain M, Mathai JP, et al. Regulation of apoptosis by endoplasmic reticulum pathways. Oncogene 2003;22(53):8608-18
38. Nakagawa T, Zhu H, Morishima N, et al. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 2000;403(6765):98-103
39. Minor T, Manekeller S, Sioutis M, Dombrowski F. Endoplasmic and vascular surface activation during organ preservation: refining upon the benefits of machine perfusion. Am J Transplant 2006;6(6):1355-66
40. Kawahara K, Oyadomari S, Gotoh T, et al. Induction of CHOP and apoptosis by nitric oxide in p53-deficient microglial cells. FEBS Lett 2001;506(2):135-9
41. Ji C, Mehrian-Shai R, Chan C, et al. Role of CHOP in hepatic apoptosis in the murine model of intragastric ethanol feeding. Alcohol Clin Exp Res 2005;29(8):1496-503
42. Urano F, Wang X, Bertolotti A, et al. Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science 2000;287(5453):664-6
43. Emadali A, Nguyen DT, Rochon C, et al. Distinct endoplasmic reticulum stress responses are triggered during human liver transplantation. J Pathol 2005;207(1):111-8
44. Blankensteijn JD, Terpstra OT. Liver preservation: the past and the future. Hepatology 1991;13(6):1235-50
45. Boudjema K, Lindell SL, Southard JH, Belzer FO. The effects of fasting on the quality of liver preservation by simple cold storage. Transplantation 1990;50(6):943-8
46. Fratte S, Gendrault JL, Steffan AM, Kirn A. Comparative ultrastructural study of rat livers preserved in Euro-Collins or University of Wisconsin solution. Hepatology 1991;13(6):1173-80
47. Pisarenko OI, Novikova EB, Serebryakova LI, et al. Function and metabolism of dog heart in ischemia and in subsequent reperfusion: effect of exogenous glutamic acid. Pflugers Arch 1985;405(4):377-83
48. Lang F, Busch GL, Zempel G, et al. Ca2+ entry and vasoconstriction during osmotic swelling of vascular smooth muscle cells. Pflugers Arch 1995;431(2):253-8
49. Ramella-Virieux SG, Steghens JP, Barbieux A, et al. Nifedipine improves recovery function of kidneys preserved in a high-sodium, low-potassium cold-storage solution: study with the isolated perfused rat kidney technique. Nephrol Dial Transplant 1997;12(3):449-55
50. Southard JH. Improving early graft function: role of preservation. Transplant Proc 1997;29(8):3510-1
51. Hochachka PW. Defense strategies against hypoxia and hypothermia. Science 1986;231(4735):234-41
52. Clavien PA, Harvey PR, Strasberg SM. Preservation and reperfusion injuries in liver allografts. An overview and synthesis of current studies. Transplantation 1992;53(5):957-78
53. Gores GJ, Nieminen AL, Wray BE, et al. Intracellular pH during "chemical hypoxia" in cultured rat hepatocytes. Protection by intracellular acidosis against the onset of cell death. J Clin Invest 1989;83(2):386-96
54. Herman B, Gores GJ, Nieminen AL, et al. Calcium and pH in anoxic and toxic injury. Crit Rev Toxicol 1990;21(2):127-48
55. Carini R, De Cesaris MG, Splendore R, et al. Alterations of Na(+) homeostasis in hepatocyte reoxygenation injury. Biochim Biophys Acta 2000;1500(3):297-305
56. Zweier JL, Flaherty JT, Weisfeldt ML. Direct measurement of free radical generation following reperfusion of ischemic myocardium. Proc Natl Acad Sci USA 1987;84(5):1404-7
57. Kim JS, Ohshima S, Pediaditakis P, Lemasters JJ. Nitric oxide: a signaling molecule against mitochondrial permeability transition- and pH-dependent cell death after reperfusion. Free Radic Biol Med 2004;37(12):1943-50
58. Halmosi R, Berente Z, Osz E, et al. Effect of poly(ADP-ribose) polymerase inhibitors on the ischemia-reperfusion-induced oxidative cell damage and mitochondrial metabolism in Langendorff heart perfusion system. Mol Pharmacol 2001;59(6):1497-505
59. Yu BP. Cellular defenses against damage from reactive oxygen species. Physiol Rev 1994;74(1):139-62
60. Ryter SW, Tyrrell RM. The heme synthesis and degradation pathways: role in oxidant sensitivity. Heme oxygenase has both pro- and antioxidant properties. Free Radic Biol Med 2000;28(2):289-309
61. Biguzas M, Jablonski P, Howden BO, et al. Evaluation of UW solution in rat kidney preservation. II. The effect of pharmacological additives. Transplantation 1990;49(6):1051-5
62. Yu WM, Coddington D, Bitter-Suermann H. Rat liver preservation. I. The components of UW solution that are essential to its success. Transplantation 1990;49(6):1060-6
63. Urushihara T, Sumimoto R, Sumimoto K, et al. A comparison of some simplified lactobionate preservation solutions with standard UW solution and Eurocollins solution for pancreas preservation. Transplantation 1992;53(4):750-4
64. Jamieson NV, Lindell S, Sundberg R, et al. An analysis of the components in UW solution using the isolated perfused rabbit liver. Transplantation 1988;46(4):512-6
65. Kevelaitis E, Nyborg NC, Menasche P. Protective effect of reduced glutathione on endothelial function of coronary arteries subjected to prolonged cold storage. Transplantation 1997;64(4):660-3
66. Boudjema K, Van Gulik TM, Lindell SL, et al. Effect of oxidized and reduced glutathione in liver preservation. Transplantation 1990;50(6):948-51
67. Upadhya GA, Strasberg SM. Glutathione, lactobionate, and histidine: cryptic inhibitors of matrix metalloproteinases contained in University of Wisconsin and histidine/tryptophan/ketoglutarate liver preservation solutions. Hepatology 2000;31(5):1115-22
68. Evans PJ, Tredger JM, Dunne JB, Halliwell B. Catalytic metal ions and the loss of reduced glutathione from University of Wisconsin preservation solution. Transplantation 1996;62(8):1046-9
69. Vreugdenhil PK, Belzer FO, Southard JH. Effect of cold storage on tissue and cellular glutathione. Cryobiology 1991;28(2):143-9
70. Polyak MM, Arrington BO, Kapur S, et al. Glutathione supplementation during cold ischemia does not confer early functional advantage in renal transplantation. Transplantation 2000;70(1):202-5
71. Lynch RJ, Kubus J, Chenault RH, et al. Comparison of histidine- tryptophan-ketoglutarate and University of Wisconsin preservation in renal transplantation. Am J Transplant 2008;8(3):567-73
72. Olschewski P, Hunold G, Eipel C, et al. Improved microcirculation by low-viscosity histidine-tryptophan-ketoglutarate graft flush and subsequent cold storage in University of Wisconsin solution: results of an orthotopic rat liver transplantation model. Transpl Int 2008;21(12):1175-80
73. Stewart ZA, Cameron AM, Singer AL, et al. Histidine-tryptophan- ketoglutarate (HTK) is associated with reduced graft survival in pancreas transplantation. Am J Transplant 2009;9(1):217-21
74. Nardo B, Catena F, Cavallari G, et al. Randomized clinical study comparing UW and Celsior solution in liver preservation for transplantation: preliminary results. Transplant Proc 2001;33(1-2):870-2
75. Pedotti P, Cardillo M, Rigotti P, et al. A comparative prospective study of two available solutions for kidney and liver preservation. Transplantation 2004;77(10):1540-5
76. Karam G, Compagnon P, Hourmant M, et al. A single solution for multiple organ procurement and preservation. Transpl Int 2005;18(6):657-63
77. Codas R, Petruzzo P, Morelon E, et al. IGL-1 solution in kidney transplantation: first multi-center study. Clin Transplant 2009;23(3):337-42
78. Yandza T, Mekaouche M, Breaud J, et al. In situ intestinal ischemia-reperfusion injury in the pig: a model using the first jejunal artery for flushing. World J Surg 2007;31(9):1863-8
79. Ben Mosbah I, Rosello-Catafau J, Franco-Gou R, et al. Preservation of steatotic livers in IGL-1 solution. Liver Transpl 2006;12(8):1215-23
80. Wojtusciszyn A, Bosco D, Morel P, et al. A comparison of cold storage solutions for pancreas preservation prior to islet isolation. Transplant Proc 2005;37(8):3396-7
81. Mor E, Schwartz ME, Sheiner PA, et al. Prolonged preservation in University of Wisconsin solution associated with hepatic artery thrombosis after orthotopic liver transplantation. Transplantation 1993;56(6):1399-402
82. Morariu AM, Plaats AVD, Oeveren WV, et al. Hyperaggregating effect of hydroxyethyl starch components and University of Wisconsin solution on human red blood cells: a risk of impaired graft perfusion in organ procurement? Transplantation 2003;76(1):37-43 • Limitation of UW preservation solution.
83. van der Plaats A, rsquot Hart NA, Morariu AM, et al. Effect of University of Wisconsin organ-preservation solution on haemorheology. Transpl Int 2004;17(5):227-33 • Haemorheology problems associated with organ preservation.
84. Mosbah IB, Franco-Gou R, Abdennebi HB, et al. Effects of polyethylene glycol and hydroxyethyl starch in University of Wisconsin preservation solution on human red blood cell aggregation and viscosity. Transplant Proc 2006;38(5):1229-35
85. Morariu AM, Maathuis MH, Asgeirsdottir SA, et al. Acute isovolemic hemodilution triggers proinflammatory and procoagulatory endothelial activation in vital organs: role of erythrocyte aggregation. Microcirculation 2006;13(5):397-409
86. Takei Y, Marzi I, Kauffman FC, et al. Increase in survival time of liver transplants by protease inhibitors and a calcium channel blocker, nisoldipine. Transplantation 1990;50(1):14-20
87. Claesson K, Lindell S, Southard JH, Belzer FO. Chlorpromazine, quinacrine, and verapamil as donor pretreatment in liver preservation, tested in the isolated perfused rat liver. Cryobiology 1991;28(5):422-7
88. Li XL, Man K, Ng KT, et al. The influence of phosphatidylinositol 3-kinase/Akt pathway on the ischemic injury during rat liver graft preservation. Am J Transplant 2005;5(6):1264-75
89. Amersi F, Nelson SK, Shen XD, et al. Bucillamine, a thiol antioxidant, prevents transplantation-associated reperfusion injury. Proc Natl Acad Sci USA 2002;99(13):8915-20
90. Yoshinari D, Takeyoshi I, Kobayashi M, et al. Effects of a p38 mitogen-activated protein kinase inhibitor as an additive to university of wisconsin solution on reperfusion injury in liver transplantation. Transplantation 2001;72(1):22-7
91. El-Gibaly AM, Scheuer C, Menger MD, Vollmar B. Improvement of rat liver graft quality by pifithrin-alpha-mediated inhibition of hepatocyte necrapoptosis. Hepatology 2004;39(6):1553-62
92. Gu XP, Xu FT, Jiang Y, et al. Pyrrolidine dithiocarbamate added to University of Wisconsin solution inhibits reperfusion injury after orthotopic liver transplantation in rats. Ann Clin Lab Sci 2004;34(2):187-94
93. Quintana AB, Rodriguez JV, Scandizzi AL, Guibert EE. The benefit of adding sodium nitroprusside (NPNa) or S-nitrosoglutathion (GSNO) to the University of Wisconsin solution (UW) to prevent morphological alterations during cold preservation/reperfusion of rat livers. Ann Hepatol 2003;2(2):84-91
94. Papanikolaou V, Vrochides D, Gakis D, et al. Improvement of rat liver graft function after storage in University of Wisconsin solution containing testicular hyaluronidase. Liver Transpl 2002;8(11):1028-35
95. Fukunaga K, Takada Y, Taniguchi H, et al. Endothelin antagonist treatment for successful liver transplantation from non-heart-beating donors. Transplantation 1999;67(2):328-32
96. Pizarro MD, Rodriguez JV, Mamprin ME, et al. Protective effects of a carbon monoxide-releasing molecule (CORM-3) during hepatic cold preservation. Cryobiology 2009;58(3):248-55
97. Selzner N, Rudiger H, Graf R, Clavien PA. Protective strategies against ischemic injury of the liver. Gastroenterology 2003;125(3):917-36
98. McLaren AJ, Friend PJ. Trends in organ preservation. Transpl Int 2003;16(10):701-8
99. Jamieson RW, Friend PJ. Organ reperfusion and preservation. Front Biosci 2008;13:221-35
100. Guarrera JV, Karim NA. Liver preservation: is there anything new yet? Curr Opin Organ Transplant 2008;13(2):148-54 •• Updated review on liver graft preservation.
101. Stanley WC, Lopaschuk GD, Hall JL, McCormack JG. Regulation of myocardial carbohydrate metabolism under normal and ischemic conditions. Potential for pharmacological interventions. Cardiovasc Res 1997;33(2):243-57
102. El Banani H, Bernard M, Baetz D, et al. Changes in intracellular sodium and pH during ischaemia-reperfusion are attenuated by trimetazidine. Comparison between low- and zero-flow ischaemia. Cardiovasc Res 2000;47(4):688-96
103. Argaud L, Gomez L, Gateau-Roesch O, et al. Trimetazidine inhibits mitochondrial permeability transition pore opening and prevents lethal ischemia-reperfusion injury. J Mol Cell Cardiol 2005;39(6):893-9
104. Wisel S, Khan M, Kuppusamy ML, et al. Pharmacological preconditioning of mesenchymal stem cells with trimetazidine (1-[2,3,4-trimethoxybenzyl]piperazine) protects hypoxic cells against oxidative stress and enhances recovery of myocardial function in infarcted heart through Bcl-2 expression. J Pharmacol Exp Ther 2009;329(2):543-50
105. Guarnieri C, Muscari C. Effect of trimetazidine on mitochondrial function and oxidative damage during reperfusion of ischemic hypertrophied rat myocardium. Pharmacology 1993;46(6):324-31
106. Hauet T, Goujon JM, Vandewalle A, et al. Trimetazidine reduces renal dysfunction by limiting the cold ischemia/reperfusion injury in autotransplanted pig kidneys. J Am Soc Nephrol 2000;11(1):138-48
107. Baumert H, Faure JP, Zhang K, et al. Evidence for a mitochondrial impact of trimetazidine during cold ischemia and reperfusion. Pharmacology 2004;71(1):25-37
108. Domanski L, Sulikowski T, Safranow K, et al. Effect of trimetazidine on the nucleotide profile in rat kidney with ischemia-reperfusion injury. Eur J Pharm Sci 2006;27(4):320-7
109. Sulikowski T, Domanski L, Ciechanowski K, et al. Effect of trimetazidine on xanthine oxidoreductase expression in rat kidney with ischemia-reperfusion injury. Arch Med Res 2008;39(4):459-62
110. Nydegger UE, Carrel T, Laumonier T, Mohacsi P. New concepts in organ preservation. Transpl Immunol 2002;9(2-4):215-25
111. Villanueva S, Cespedes C, Gonzalez A, Vio CP. bFGF induces an earlier expression of nephrogenic proteins after ischemic acute renal failure. Am J Physiol Regul Integr Comp Physiol 2006;291(6):R1677-87
112. Cau J, Favreau F, Tillement JP, et al. Trimetazidine reduces early and long-term effects of experimental renal warm ischemia: a dose effect study. J Vasc Surg 2008;47(4):852-60
113. Jayle C, Favreau F, Zhang K, et al. Comparison of protective effects of trimetazidine against experimental warm ischemia of different durations: early and long-term effects in a pig kidney model. Am J Physiol Renal Physiol 2007;292(3):F1082-93
114. Zahedi K, Wang Z, Barone S, et al. Identification of stathmin as a novel marker of cell proliferation in the recovery phase of acute ischemic renal failure. Am J Physiol Cell Physiol 2004;286(5):C1203-11
115. Doucet C, Dutheil D, Petit I, et al. Influence of colloid, preservation medium and trimetazidine on renal medulla injury. Biochim Biophys Acta 2004;1673(3):105-14
116. Faure JP, Petit I, Zhang K, et al. Protective roles of polyethylene glycol and trimetazidine against cold ischemia and reperfusion injuries of pig kidney graft. Am J Transplant 2004;4(4):495-504
117. Castedo E, Segovia J, Escudero C, et al. Ischemia-reperfusion injury during experimental heart transplantation. Evaluation of trimetazidine's cytoprotective effect. Rev Esp Cardiol 2005;58(8):941-50
118. Ben Mosbah I, Casillas-Ramirez A, Xaus C, et al. Trimetazidine: is it a promising drug for use in steatotic grafts? World J Gastroenterol 2006;12(6):908-14
119. Ben Mosbah I, Massip-Salcedo M, Fernandez-Monteiro I, et al. Addition of adenosine monophosphate-activated protein kinase activators to University of Wisconsin solution: a way of protecting rat steatotic livers. Liver Transpl 2007;13(3):410-25
120. Lu C, Dabrowski P, Fragasso G, Chierchia SL. Effects of trimetazidine on ischemic left ventricular dysfunction in patients with coronary artery disease. Am J Cardiol 1998;82(7):898-901
121. Belardinelli R, Purcaro A. Effects of trimetazidine on the contractile response of chronically dysfunctional myocardium to low-dose dobutamine in ischaemic cardiomyopathy. Eur Heart J 2001;22(23):2164-70
122. Szwed H, Sadowski Z, Elikowski W, et al. Combination treatment in stable effort angina using trimetazidine and metoprolol: results of a randomized, double-blind, multicentre study (TRIMPOL II). TRIMetazidine in POLand. Eur Heart J 2001;22(24):2267-74
123. Marzilli M, Klein WW. Efficacy and tolerability of trimetazidine in stable angina: a meta-analysis of randomized, double-blind, controlled trials. Coron Artery Dis 2003;14(2):171-9
124. Di Napoli P, Di Giovanni P, Gaeta MA, et al. Trimetazidine and reduction in mortality and hospitalization in patients with ischemic dilated cardiomyopathy: a post hoc analysis of the Villa Pini d'Abruzzo Trimetazidine Trial. J Cardiovasc Pharmacol 2007;50(5):585-9
125. Iskesen I, Kurdal AT, Eserdag M, et al. Trimetazidine may protect the myocardium during cardiac surgery. Heart Surg Forum 2009;12(3):E175-9
126. Boni LT, Hah JS, Hui SW, et al. Aggregation and fusion of unilamellar vesicles by poly(ethylene glycol). Biochim Biophys Acta 1984;775(3):409-18
127. Hauet T, Eugene M. A new approach in organ preservation: potential role of new polymers. Kidney Int 2008;74(8):998-1003 •• Use of new polymers in kidney preservation.
128. Stefanovich P, Ezzell RM, Sheehan SJ, et al. Effects of hypothermia on the function, membrane integrity, and cytoskeletal structure of hepatocytes. Cryobiology 1995;32(4):389-403
129. Mack JE, Kerr JA, Vreugdenhil PK, et al. Effect of polyethylene glycol on lipid peroxidation in cold-stored rat hepatocytes. Cryobiology 1991;28(1):1-7
130. Perrin H, Thaunat O, Malcus C, et al. Immunoprotection by polyethylene glycol in organ preservation solutions is not due to an immunomasking effect. Nephrol Dial Transplant 2009;24(5):1682-5
131. Eugene M. Polyethyleneglycols and immunocamouflage of the cells tissues and organs for transplantation. Cell Mol Biol (Noisy-le-grand) 2004;50(3):209-15
132. Hauet T, Goujon JM, Baumert H, et al. Polyethylene glycol reduces the inflammatory injury due to cold ischemia/ reperfusion in autotransplanted pig kidneys. Kidney Int 2002;62(2):654-67
133. Rubio-Gayosso I, Platts SH, Duling BR. Reactive oxygen species mediate modification of glycocalyx during ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 2006;290(6):H2247-56
134. Zheng TL, Lanza RP, Soon-Shiong P. Prolonged pancreas preservation using a simplified UW solution containing polyethylene glycol. Transplantation 1991;51(1):63-6
135. Wicomb WN, Collins AB, Tokunaga Y, Esquivel C. Choice of cation in solutions for hypothermic storage of liver and heart. High-sodium versus high-potassium. Transplantation 1991;51(1):281-2
136. Ben Abdennebi H, Steghens JP, Hadj-Aissa A, et al. A preservation solution with polyethylene glycol and calcium: a possible multiorgan liquid. Transpl Int 2002;15(7):348-54
137. Dutheil D, Rioja-Pastor I, Tallineau C, et al. Protective effect of PEG 35,000 Da on renal cells: paradoxical activation of JNK signaling pathway during cold storage. Am J Transplant 2006;6(7):1529-40
138. Zarubin T, Han J. Activation and signaling of the p38 MAP kinase pathway. Cell Res 2005;15(1):11-8
139. Badet L, Ben Abdennebi H, Petruzzo P, et al. Effect of IGL-1, a new preservation solution, on kidney grafts (a pre-clinical study). Transpl Int 2005;17(12):815-21
140. Vairetti M, Ferrigno A, Bertone R, et al. Exogenous melatonin enhances bile flow and ATP levels after cold storage and reperfusion in rat liver: implications for liver transplantation. J Pineal Res 2005;38(4):223-30
141. Deniz E, Colakoglu N, Sari A, et al. Melatonin attenuates renal ischemia-reperfusion injury in nitric oxide synthase inhibited rats. Acta Histochem 2006;108(4):303-9
142. Munoz-Casares FC, Padillo FJ, Briceno J, et al. Melatonin reduces apoptosis and necrosis induced by ischemia/reperfusion injury of the pancreas. J Pineal Res 2006;40(3):195-203
143. Jung FJ, Yang L, Harter L, et al. Melatonin in vivo prolongs cardiac allograft survival in rats. J Pineal Res 2004;37(1):36-41
144. Inci I, Inci D, Dutly A, et al. Melatonin attenuates posttransplant lung ischemia-reperfusion injury. Ann Thorac Surg 2002;73(1):220-5
145. Cuzzocrea S, Costantino G, Mazzon E, et al. Beneficial effects of melatonin in a rat model of splanchnic artery occlusion and reperfusion. J Pineal Res 2000;28(1):52-63
146. Pei Z, Pang SF, Cheung RT. Pretreatment with melatonin reduces volume of cerebral infarction in a rat middle cerebral artery occlusion stroke model. J Pineal Res 2002;32(3):168-72
147. Poeggeler B, Reiter RJ, Tan DX, et al. Melatonin, hydroxyl radical-mediated oxidative damage, and aging: a hypothesis. J Pineal Res 1993;14(4):151-68
148. Marshall KA, Reiter RJ, Poeggeler B, et al. Evaluation of the antioxidant activity of melatonin in vitro. Free Radic Biol Med 1996;21(3):307-15
149. Lee YM, Chen HR, Hsiao G, et al. Protective effects of melatonin on myocardial ischemia/reperfusion injury in vivo. J Pineal Res 2002;33(2):72-80
150. Pierrefiche G, Topall G, Courboin G, et al. Antioxidant activity of melatonin in mice. Res Commun Chem Pathol Pharmacol 1993;80(2):211-23
151. Dugo L, Serraino I, Fulia F, et al. Effect of melatonin on cellular energy depletion mediated by peroxynitrite and poly (ADP-ribose) synthetase activation in an acute model of inflammation. J Pineal Res 2001;31(1):76-84
152. Blanchard B, Pompon D, Ducrocq C. Nitrosation of melatonin by nitric oxide and peroxynitrite. J Pineal Res 2000;29(3):184-92
153. Acuna-Castroviejo D, Martin M, Macias M, et al. Melatonin, mitochondria, and cellular bioenergetics. J Pineal Res 2001;30(2):65-74
154. Reiter RJ, Tan DX, Manchester LC, El-Sawi MR. Melatonin reduces oxidant damage and promotes mitochondrial respiration: implications for aging. Ann NY Acad Sci 2002;959:238-50
155. Freitas I, Bertone V, Guarnaschelli C, et al. In situ demonstration of improvement of liver mitochondria function by melatonin after cold ischemia. In Vivo 2006;20(2):229-37
156. Petrosillo G, Di Venosa N, Pistolese M, et al. Protective effect of melatonin against mitochondrial dysfunction associated with cardiac ischemia- reperfusion: role of cardiolipin. FASEB J 2006;20(2):269-76
157. Antolin I, Rodriguez C, Sainz RM, et al. Neurohormone melatonin prevents cell damage: effect on gene expression for antioxidant enzymes. FASEB J 1996;10(8):882-90
158. Cuzzocrea S, Reiter RJ. Pharmacological action of melatonin in shock, inflammation and ischemia/reperfusion injury. Eur J Pharmacol 2001;426(1-2):1-10
159. Lezoualc'h F, Sparapani M, Behl C. N-acetyl-serotonin (normelatonin) and melatonin protect neurons against oxidative challenges and suppress the activity of the transcription factor NF-kappaB. J Pineal Res 1998;24(3):168-78
160. Tan DX, Manchester LC, Reiter RJ, et al. A novel melatonin metabolite, cyclic 3-hydroxymelatonin: a biomarker of in vivo hydroxyl radical generation. Biochem Biophys Res Commun 1998;253(3):614-20
161. Pieri C, Marra M, Moroni F, et al. Melatonin: a peroxyl radical scavenger more effective than vitamin E. Life Sci 1994;55(15):PL271-6
162. Reiter RJ, Tan D, Kim SJ, et al. Augmentation of indices of oxidative damage in life-long melatonin-deficient rats. Mech Ageing Dev 1999;110(3):157-73
163. Sewerynek E, Poeggeler B, Melchiorri D, Reiter RJ. H2O2-induced lipid peroxidation in rat brain homogenates is greatly reduced by melatonin. Neurosci Lett 1995;195(3):203-5
164. Urata Y, Honma S, Goto S, et al. Melatonin induces gamma-glutamylcysteine synthetase mediated by activator protein-1 in human vascular endothelial cells. Free Radic Biol Med 1999;27(7-8):838-47
165. Cuzzocrea S, Mazzon E, Serraino I, et al. Melatonin reduces dinitrobenzene sulfonic acid-induced colitis. J Pineal Res 2001;30(1):1-12
166. Li Z, Nickkholgh A, Yi X, et al. Melatonin protects kidney grafts from ischemia/ reperfusion injury through inhibition of NF-kB and apoptosis after experimental kidney transplantation. J Pineal Res 2009;46(4):365-72
167. Baxter GF, Mocanu MM, Brar BK, et al. Cardioprotective effects of transforming growth factor-beta1 during early reoxygenation or reperfusion are mediated by p42/p44 MAPK. J Cardiovasc Pharmacol 2001;38(6):930-9
168. Yamashita K, Kajstura J, Discher DJ, et al. Reperfusion-activated Akt kinase prevents apoptosis in transgenic mouse hearts overexpressing insulin-like growth factor-1. Circ Res 2001;88(6):609-14
169. Buehler A, Martire A, Strohm C, et al. Angiogenesis-independent cardioprotection in FGF-1 transgenic mice. Cardiovasc Res 2002;55(4):768-77
170. Takeda Y, Arii S, Kaido T, et al. Morphologic alteration of hepatocytes and sinusoidal endothelial cells in rat fatty liver during cold preservation and the protective effect of hepatocyte growth factor. Transplantation 1999;67(6):820-8
171. Takeda Y, Arii S, Kaido T, Imamura M. The impairment of hepatocytes and sinusoidal endothelial cells during cold preservation in rat fatty liver induced by alcohol and the beneficial effect of hepatocyte growth factor. Transpl Int 2003;16(4):241-9
172. McAnulty JF, Reid TW, Waller KR, Murphy CJ. Successful six-day kidney preservation using trophic factor supplemented media and simple cold storage. Am J Transplant 2002;2(8):712-8
173. Ambiru S, Uryuhara K, Talpe S, et al. Improved survival of orthotopic liver allograft in swine by addition of trophic factors to University of Wisconsin solution. Transplantation 2004;77(2):302-19
174. Boros P, Tarcsafalvi A, Wang L, et al. Intrahepatic expression and release of vascular endothelial growth factor following orthotopic liver transplantation in the rat. Transplantation 2001;72(5):805-11
175. Luo Z, Diaco M, Murohara T, et al. Vascular endothelial growth factor attenuates myocardial ischemia-reperfusion injury. Ann Thorac Surg 1997;64(4):993-8
176. Tsurui Y, Sho M, Kuzumoto Y, et al. Dual role of vascular endothelial growth factor in hepatic ischemia-reperfusion injury. Transplantation 2005;79(9):1110-5
177. Goto M, Takei Y, Kawano S, et al. Endothelin-1 is involved in the pathogenesis of ischemia/reperfusion liver injury by hepatic microcirculatory disturbances. Hepatology 1994;19(3):675-81
178. Okumura S, Takei Y, Kawano S, et al. Vasoactive effect of endothelin-1 on rat liver in vivo. Hepatology 1994;19(1):155-61
179. Kawamura E, Yamanaka N, Okamoto E, et al. Response of plasma and tissue endothelin-1 to liver ischemia and its implication in ischemia-reperfusion injury. Hepatology 1995;21(4):1138-43
180. Nakamura S, Nishiyama R, Serizawa A, et al. Hepatic release of endothelin-1 after warm ischemia. Reperfusion injury and its hemodynamic effect. Transplantation 1995;59(5):679-84
181. Uhlmann D, Gaebel G, Armann B, et al. Attenuation of proinflammatory gene expression and microcirculatory disturbances by endothelin A receptor blockade after orthotopic liver transplantation in pigs. Surgery 2006;139(1):61-72
182. Charrueau CA, Carayon A, Thurman RG. Long-term cold liver storage induces endothelin-1 release and a time-dependent increase in portal pressure at reperfusion in the rat. J Gastroenterol 2002;37(9):717-25
183. Kraus T, Klar E, Mehrabi A, et al. Endothelin 1/2 and big-endothelin concentration in bile samples during the early postoperative period after liver transplantation. Transplant Proc 1995;27(1):1258-60
184. Stansby G, Fuller B, Jeremy J, et al. Endothelin release-a facet of reperfusion injury in clinical liver transplantation? Transplantation 1993;56(1):239-40
185. Mehrabi A, Kraus TW, Klar E, et al. Analysis of extravascular endothelin levels in UW solution and rinsing effluent of porcine liver grafts after cold storage. Transplant Proc 1995;27(5):2613-5
186. Gu M, Takada Y, Fukunaga K, et al. Pharmacologic graft protection without donor pretreatment in liver transplantation from non-heart-beating donors. Transplantation 2000;70(7):1021-5
187. Kiuchi T, Tanaka K, Ito T, et al. Small-for-size graft in living donor liver transplantation: how far should we go? Liver Transpl 2003;9(9):S29-35
188. Palmes D, Minin E, Budny T, et al. The endothelin/nitric oxide balance determines small-for-size liver injury after reduced-size rat liver transplantation. Virchows Arch 2005;447(4):731-41
189. Taylor MJ, Baicu SC. Current state of hypothermic machine perfusion preservation of organs: the clinical perspective. Cryobiology. 24 Oct 2009 [Epub ahead of print]
190. Moers C, Smits JM, Maathuis MH, et al. Machine perfusion or cold storage in deceased-donor kidney transplantation. N Engl J Med 2009;360(1):7-19 •• Advantages of hypothermic machine perfusion for graft preservation.
191. Guarrera JV, Henry SD, Samstein B, et al. Hypothermic machine preservation in human liver transplantation: the first clinical series. Am J Transplant. 2 Dec 2009 [Epub ahead of print] •• First clinical application of hypothermic machine perfusion for liver grafts.
192. Vairetti M, Ferrigno A, Carlucci F, et al. Subnormothermic machine perfusion protects steatotic livers against preservation injury: a potential for donor pool increase? Liver Transpl 2009;15(1):20-9
193. Butler AJ, Rees MA, Wight DG, et al. Successful extracorporeal porcine liver perfusion for 72 hr. Transplantation 2002;73(8):1212-8 •• Normothermic organ preservation, as new strategy for liver grafts preservation.
194. Brockmann J, Reddy S, Coussios C, et al. Normothermic perfusion: a new paradigm for organ preservation. Ann Surg 2009;250(1):1-6
195. Bagul A, Hosgood SA, Kaushik M, et al. Experimental renal preservation by normothermic resuscitation perfusion with autologous blood. Br J Surg 2008;95(1):111-8
196. D'Alessandro AM. Normothermic liver preservation: is it time to come in from the cold? Ann Surg 2009;250(1):7-9
197. Monbaliu D, Vekemans K, Hoekstra H, et al. Multifactorial biological modulation of warm ischemia reperfusion injury in liver transplantation from non-heart-beating donors eliminates primary nonfunction and reduces bile salt toxicity. Ann Surg 2009;250(5):808-17 •• Importance of multifactorial modulation in warm ischemia reperfusion injury associated to liver transplantation.
198. Maathuis MH, Leuvenink HG, Ploeg RJ. Perspectives in organ preservation. Transplantation 2007;83(10):1289-98
199. Menasche P, Termignon JL, Pradier F, et al. Experimental evaluation of Celsior, a new heart preservation solution. Eur J Cardiothorac Surg 1994;8(4):207-13
200. Straatsburg IH, Abrahamse SL, Song SW, et al. Evaluation of rat liver apoptotic and necrotic cell death after cold storage using UW, HTK, and Celsior. Transplantation 2002;74(4):458-64
201. Kerkweg U, Li T, de Groot H, Rauen U. Cold-induced apoptosis of rat liver cells in University of Wisconsin solution: the central role of chelatable iron. Hepatology 2002;35(3):560-7
202. Schmeding M, Hunold G, Ariyakhagorn V, et al. Erythropoietin reduces ischemia-reperfusion injury after liver transplantation in rats. Transpl Int 2009;22(7):738-46